FDA PMA FDA Class 3 Approved 🇺🇸 United States

Catheter, Percutaneous Transluminal Coronary Angioplasty (Ptca), Cutting/Scoring

PMA: P950020 · Supplement: S072 · Decision Aug 18, 2016
Classifications
1
FEI Numbers
12
Registration Numbers
12

Basic Information

Device Name
Catheter, Percutaneous Transluminal Coronary Angioplasty (Ptca), Cutting/Scoring
Trade Name
WOLVERINE CORONARY CUTTING BALLOON (MONORAIL & OVER-THE-WIRE)
PMA Number
P950020
Supplement Number
S072
Device Class
FDA Class 3
Product Code
NWX
Generic Name
Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
August 18, 2016
Date Received
January 29, 2016
Supplement Type
Normal 180 Day Track
Expedited Review
N

Advisory Committee Statement

Approval for updates to the atherotomes, adhesive, balloon catheter platform, device packaging and the sterilization process. The device, as modified, will be marketed under the trade name WOLVERINE Coronary Cutting Balloon (Monorail & Over-The-Wire) and is indicated for dilatation of stenoses in coronary arteries for the purpose of improving myocardial perfusion in those circumstances where a high pressure balloon resistant lesion is encountered. In addition, the target lesion should possess the following characteristics: Discrete (<15 mm in length), or tubular (10 mm to 20 mm in length); Reference Vessel Diameter (RVD) of 2.00 mm to 4.00 mm; Readily accessible to the device; Light to moderate tortuosity of proximal vessel segment; Non-angulated lesion segment (<45 Degrees); Smooth angiographic contour; Absence of angiographically visible thrombus and/or calcification.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NWX Catheter, Percutaneous Transluminal Coronary Angioplasty (Ptca), Cutting/Scoring